A Randomized, Double Blind, Placebo‐Controlled Trial of an Oral Synbiotic (AKSB) for Prevention of Travelers' Diarrhea | Zendy

Abinash Virk | Zendy; Jayawant N. Mandrekar | Zendy; Elie F. Berbari | Zendy; Thomas G. Boyce | Zendy; Philip R. Fischer | Zendy; Mary J. Kasten | Zendy; Robert Orenstein | Zendy; Jon E. Rosenblatt | Zendy; Priya Sampathkumar | Zendy; Irene G. Sia | Zendy; Donna J. Springer | Zendy; Thomas E. Witzig | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Randomized, Double Blind, Placebo‐Controlled Trial of an Oral Synbiotic (AKSB) for Prevention of Travelers' Diarrhea

Author(s) -

Abinash Virk,

Jayawant N. Mandrekar,

Elie F. Berbari,

Thomas G. Boyce,

Philip R. Fischer,

Mary J. Kasten,

Robert Orenstein,

Jon E. Rosenblatt,

Priya Sampathkumar,

Irene G. Sia,

Donna J. Springer,

Thomas E. Witzig

Publication year - 2013

Publication title -

journal of travel medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.985

H-Index - 59

eISSN - 1708-8305

pISSN - 1195-1982

DOI - 10.1111/jtm.12008

Subject(s) - medicine , traveler's diarrhea , diarrhea , placebo , antibiotic associated diarrhea , placebo controlled study , randomized controlled trial , antibiotics , double blind , alternative medicine , microbiology and biotechnology , pathology , biology , clostridium difficile

Travelers' diarrhea (TD) is a significant problem for travelers. TD is treatable once it occurs, but few options for prevention exist. Probiotics have been studied for prevention or treatment of TD; however, very few combination probiotics have been studied. Therefore, the purpose of this study was to determine if prophylactic use of an oral synbiotic could reduce the risk of acquiring TD and reduce antibiotic use if TD occurred.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research